Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 4
1983 1
1987 3
1988 2
1989 1
1990 3
1991 5
1992 4
1993 4
1994 3
1995 2
1996 1
1997 2
1998 4
1999 6
2000 4
2001 3
2002 4
2003 4
2004 4
2005 3
2006 2
2007 3
2008 1
2009 3
2010 5
2011 5
2012 1
2013 3
2014 6
2015 9
2016 8
2017 8
2018 5
2019 11
2020 10
2021 12
2022 6
2023 10
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

164 results

Results by year

Filters applied: . Clear all
Page 1
Management of children and adolescents with chronic myeloid leukemia in blast phase: International pediatric CML expert panel recommendations.
Sembill S, Ampatzidou M, Chaudhury S, Dworzak M, Kalwak K, Karow A, Kiani A, Krumbholz M, Luesink M, Naumann-Bartsch N, De Moerloose B, Osborn M, Schultz KR, Sedlacek P, Giona F, Zwaan CM, Shimada H, Versluijs B, Millot F, Hijiya N, Suttorp M, Metzler M. Sembill S, et al. Among authors: millot f. Leukemia. 2023 Mar;37(3):505-517. doi: 10.1038/s41375-023-01822-2. Epub 2023 Jan 27. Leukemia. 2023. PMID: 36707619 Free PMC article. Review.
Molecular and clinicopathologic characterization of pediatric histiocytoses.
Hélias-Rodzewicz Z, Donadieu J, Terrones N, Barkaoui MA, Lambilliotte A, Moshous D, Thomas C, Azarnoush S, Pasquet M, Mansuy L, Aladjidi N, Jeziorski E, Marec-Berard P, Gilibert-Yvert M, Spiegel A, Saultier P, Pellier I, Pagnier A, Pertuisel S, Poiree M, Bodet D, Millot F, Isfan F, Stephan JL, Leruste A, Rigaud C, Filhon B, Carausu L, Reguerre Y, Kieffer I, Brichard B, Ben Jannet R, Bakari M, Idbaih A, Bodemer C, Cohen-Aubart F, Haroche J, Tazi A, Boudjemaa S, Fraitag S, Emile JF, Heritier S; French Histiocytosis Study Group. Hélias-Rodzewicz Z, et al. Among authors: millot f. Am J Hematol. 2023 Jul;98(7):1058-1069. doi: 10.1002/ajh.26938. Epub 2023 Apr 28. Am J Hematol. 2023. PMID: 37115038
Pharmacology and pharmacokinetics of imatinib in pediatric patients.
Suttorp M, Bornhäuser M, Metzler M, Millot F, Schleyer E. Suttorp M, et al. Among authors: millot f. Expert Rev Clin Pharmacol. 2018 Mar;11(3):219-231. doi: 10.1080/17512433.2018.1398644. Epub 2017 Nov 6. Expert Rev Clin Pharmacol. 2018. PMID: 29076384 Review.
Neuroblastoma in adolescents.
Gaspar N, Hartmann O, Munzer C, Bergeron C, Millot F, Cousin-Lafay L, Babin-Boilletot A, Blouin P, Pajot C, Coze C. Gaspar N, et al. Among authors: millot f. Cancer. 2003 Jul 15;98(2):349-55. doi: 10.1002/cncr.11521. Cancer. 2003. PMID: 12872356 Free article.
Management of chronic myeloid leukemia in childhood.
Suttorp M, Eckardt L, Tauer JT, Millot F. Suttorp M, et al. Among authors: millot f. Curr Hematol Malig Rep. 2012 Jun;7(2):116-24. doi: 10.1007/s11899-012-0113-6. Curr Hematol Malig Rep. 2012. PMID: 22395816 Review.
Neurological Involvement in Childhood Evans Syndrome.
Pincez T, Neven B, Le Pointe HD, Varlet P, Fernandes H, Gareton A, Leverger G, Leblanc T, Chambost H, Michel G, Pasquet M, Millot F, Hermine O, Mathian A, Hully M, Zephir H, Hamidou M, Durand JM, Perel Y, Landman-Parker J, Rieux-Laucat F, Aladjidi N. Pincez T, et al. Among authors: millot f. J Clin Immunol. 2019 Feb;39(2):171-181. doi: 10.1007/s10875-019-0594-3. Epub 2019 Jan 22. J Clin Immunol. 2019. PMID: 30671780 Free article.
Interferon therapy in chronic myelogenous leukemia.
Guilhot F, Roy L, Guilhot J, Millot F. Guilhot F, et al. Among authors: millot f. Hematol Oncol Clin North Am. 2004 Jun;18(3):585-603, viii. doi: 10.1016/j.hoc.2004.03.002. Hematol Oncol Clin North Am. 2004. PMID: 15271394 Review.
The long-term efficacy and safety of nilotinib in pediatric patients with CML: a 5-year update of the DIALOG study.
Hijiya N, Maschan A, Rizzari C, Shimada H, Dufour C, Goto H, Kang HJ, Guinipero T, Karakas Z, Bautista F, Ducassou S, Yoo KH, Zwaan CM, Millot F, Patterson BC, Samis J, Izquierdo M, Titorenko K, Li S, Sosothikul D. Hijiya N, et al. Among authors: millot f. Blood Adv. 2023 Dec 12;7(23):7279-7289. doi: 10.1182/bloodadvances.2023010122. Blood Adv. 2023. PMID: 37738125 Free PMC article.
164 results